Subscribe for Updates

Berkley Renewables Inc. is a growth-oriented venture firm pursuing opportunities in Renewable Energy, Life Sciences and the Oil & Gas sectors. The company is currently pursuing unique solar energy investments in Ontario, Canada. Berkley has diversified by purchasing an equity interest in RepliCel Life Sciences Inc., a clinical stage regenerative medicine company focused on the development of autologous cell therapies. RepliCel is developing a scientific technology with the potential to become the world's first, minimally invasive, permanent solution for hair loss in men and women.
December 10, 2014
RepliCel receives Health Canada clearance for Chronic Achilles Tendinosis treatment trial
November 26, 2014
RepliCel submits clinical trial application to Health Canada for Chronic Achilles Tendinosis treatment
October 30, 2014
RepliCel presents clinical trial updates
September 25, 2014
Latest News on Berkley Interests
Tue Sep 30, 2014
2014 Q3